Published Oct 13, 2015
Princeton, NJ—October 13, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that its 18th Annual European Congress has registered a record number of delegates for this annual meeting. The Congress will be held 7-11 November 2015 in Milan, Italy. “This year’s European Congress has surpassed expectations with nearly 4,000 delegates registered to date, “ noted Nancy Berg, chief executive officer and executive director of ISPOR. “We anticipate a substantial increase over last year’s Congress with final registration numbers to exceed 5,000. Every year ISPOR strives to elevate the value of ISPOR meetings for our members. We are encouraged to see such a substantial increase in this year’s Congress attendance as it reflects the key value of ISPOR meetings as consensus building, information sharing, and networking platforms.” The ISPOR Annual European Congress is a leading forum for discussion and dissemination of information surrounding the science of health economics and outcomes research. This year’s 18th Annual Congress is focusing on “Impacting Health Decision Making with Outcomes Research: Closing the Gap.” The Congress will be co-chaired by François Meyer, MD, Advisor to the President, International Affairs, French National Authority for Health (HAS), Saint-Denis La Plaine, France and Lorenzo G. Mantovani, DSc, Associate Professor of Public Health, Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy. Registration is currently open for the Congress and additional information may be found at The ISPOR 18th Annual European Congress features three plenary sessions and over 2,450 research presentations. The Congress plenaries include the following with additional information available at First Plenary SessionStrategy in Motion: The Current and Future Lifecycle Approach to Decision Making on Health Technologies (Monday, 9 November 2015) Second Plenary SessionOutcomes Research: Are We Ready to Put Theory into Practice? (Tuesday, 10 November 2015) Third Plenary SessionRecommendations from the ISPOR Multi-Criteria Decision Analysis Emerging Good Practice Task Force and Remaining Controversies (Wednesday, 11 November 2015)


Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now